CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
MONDAY 05 SEPTEMBER, 2016
OA1971
OA1972
OA1973
OA1974
OA1975
LATE-BREAKING ABSTRACT: Exploiting the ability of 1 H-NMR to differentiate patients with severe alpha-1-
antitrypsin deficiency from controls based on metabolome profiling of exhaled breath condensate
Jan Stolk (Leiden, Netherlands), M. Fumagalli, Jan Stolk, C. Ciaramelli, R. Bussei, V. Mazzoni, S. Viglio, Paolo Iadarola,
C. Airoldi
LATE-BREAKING ABSTRACT: TRINITY: A phase III study to compare the efficacy and safety of an extrafine
triple combination of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium bromide
(GB) pMDI (CHF5993) with tiotropium (Tio) and a free triple combination of BDP/FF (Foster®) + Tio in COPD
patients
Jørgen Vestbo (Manchester, United Kingdom), Jorgen Vestbo, Massimo Corradi, Isabella Montagna, Géraldine Cohuet,
Catherine Francisco, Stefano Vezzoli, Annamaria Muraro, Stefano Petruzzelli, Mario Scuri, Dave Singh
LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in
COPD
Peter M. A. Calverley (Liverpool, United Kingdom), Peter M.A. Calverley, Kay Tetzlaff, Claus Vogelmeier, Leonardo M.
Fabbri, Helgo Magnussen, Emiel F.M. Wouters, Bernd Disse, Helen Finnigan, Guus M. Asijee, Henrik Watz
LATE-BREAKING ABSTRACT: The PDE4 inhibitor CHF-6001 and LAMAs cooperatively inhibit
bronchoconstriction-induced remodeling in lung slices
Loes Kistemaker (Groningen, Netherlands), Loes E.M. Kistemaker, Tjitske A. Oenema, Wim A. de Jager, I. Sophie T. Bos,
Fabrizio Facchinetti, Gino Villetti, Reinoud Gosens
LATE-BREAKING ABSTRACT: LAVOLTA I and II: Results of 2 phase III studies to assess the efficacy and safety
of lebrikizumab in patients with uncontrolled asthma
Nicola Hanania (Houston, United States of America), Nicola Hanania, Phillip Korenblat, Kenneth R. Chapman, Eric D.
Bateman, Petr Kopecky, Pier L. Paggiaro, Akihito Yokoyama, Julie Olsson, Sarah Gray, Cecile T.J. Holweg, Mark Eisner,
Charles Asare, John G. Matthews
OA1976
LATE-BREAKING ABSTRACT: Tackling the burden of chronic cough: A dose escalation study of AF-219
Jaclyn Smith (Manchester, United Kingdom), Jaclyn Smith, Michael Kitt, Mandel Sher, Peter Butera, Anthony Ford
Room G Session 358 10:45 - 12:45
Oral Presentation: Clinical and molecular studies in asthma
Chairs : Apostolos Bossios (Gothenburg, Sweden), Hans Jürgen Heinrich Hoffmann (Århus, Denmark)
OA1977
LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe
exacerbation of experimental asthma
Lara Ravanetti (Amsterdam, Netherlands), Lara Ravanetti, Annemiek Dijhuis, Yanaika Sabogal Pineros, Renè Lutter
OA1978
OA1979
OA1980
OA1981
OA1982
OA1983
OA1984
Prothrombotic alterations to blood coagulation and fibrinolysis in clinically stable asthma
Agnieszka Cybulska (Kraków, Poland), Agnieszka Cybulska, Stanislawa Bazan-Socha, Lucyna Mastalerz, Lech Zareba,
Romy Kremers, Michal Zabczyk, Grazyna Pulka, Teresa Iwaniec, Anetta Undas
Interleukin-33 and Th2 cytokines correlate in acute asthma
Nadia Nicholine Poulsen (Copenhagen , Denmark), Nadia Nicholine Poulsen, Asger Bjerregaard, Siew-Kim Khoo, Ingrid A.
Laing, Peter N. Le Souëf, Vibeke Backer, Lucy Barret, Phillip J. Thompson, Svetlana Baltic, Celeste Porsbjerg
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma
biomarker
Masayuki Takai (Sagamihara, Japan), Masayuki Takai, Junya Ono, Ayami Kamei, Hisako Matsumoto, Shoichiro Ohta,
Kenji Izuhara
Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy
Eric D. Bateman (Cape Town, South Africa), Eric D. Bateman, Alfredo Guerreros, Florian Brockhaus, Bjoern Holzhauer,
Abhijit Pethe, Richard Kay, Robert G. Townley
Crucial timing of a viral component exposure to exacerbate allergen-induced asthma
Shigeru Ashino (Tokyo, Japan), Shigeru Ashino, Keisuke Orimo, Kiyoshi Takeyama, Jun Tamaoki, Junji Yagi
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in
subjects with asthma
Nikolaos Lazarinis (Stockholm, Sweden), Nikolaos Lazarinis, Johan Bood, Cristina Gomez, Johan Kolmert, Jesper Säfholm,
Ann-Sofie Lantz, Elisabeth Henriksson, Craig Wheelock, Sven-Erik Dahlén, Barbro Dahlén
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult
asthmatics
Ioana Agache (BRASOV/BRASOV, Romania), Ioana Agache, Daniel S. Strassser, Axel Klenk, Costel Agache, Hervé
Farine, Cristina Ciobanu, Peter M.A. Groenen, Cezmi A. Akdis
139 26.08.2016